| | | | Founder of 7 different companies, notably: Royalty Pharma Plc, Cibus Corp. and Syntax Analytics LLC, Rory B. Riggs is an entrepreneur and businessperson who has been at the head of 15 different companies and currently holds the position of Chairman for Cibus Corp. (which he founded in 2001), Chairman of Nucelis, Inc., Chairman at Cibus Ltd. and Chairman of Cibus US LLC (which are all subsidiaries of Cibus Corp.), Chairman of RP Management LLC (which he founded in 1996), Chief Executive Officer at Syntax Analytics LLC (which he founded in 2010), Chief Executive Officer at Locus Analytics LLC (which he founded in 2010), Chief Executive Officer at Syntax LLC (which he founded in 2010) and Chief Executive Officer at Syntax Advisors LLC (which he founded), Chief Executive Officer & Trustee at Syntax ETF Trust (a subsidiary of Syntax Advisors LLC). Mr. Riggs is also Managing Member at Balfour Venture Partners and on the board of 8 other companies.
Rory B. Riggs previously occupied the position of Managing Member at Balfour LLC, President & Chief Executive Officer for The RF&P Corp., Associate for Strategic Planning Associates, President, Chief Financial Officer & Director at Biomatrix, Inc., Managing Director at PaineWebber, Inc., Principal at Pacific Media Partners, Inc. and Managing Member at New Ventures I LLC.
Rory B. Riggs received an undergraduate degree from Middlebury College and an MBA from Columbia Business School.
| | Postes et responsabilits de Rory B. Riggs | | | | Nom | Titre | Depuis |  Royalty Pharma plc
(Produits pharmaceutiques) | Director | 2020 | FibroGen, Inc.
(Recherche biotechnologique et mdicale) | Independent Director | 1993 | Intra-Cellular Therapies, Inc.
(Recherche biotechnologique et mdicale) | Independent Director | 2014 |  StageZero Life Sciences Ltd.
(Recherche biotechnologique et mdicale) | Independent Director | 2013 | Cibus Global, Ltd.
(Pche et agriculture) | Chairman | 2014 | | Syntax Analytics LLC | Chief Executive Officer | 2010 | | Locus Analytics LLC | Chief Executive Officer | 2010 | | Syntax Advisors LLC | Chief Executive Officer | - | | Syntax LLC | Chief Executive Officer | 2010 | | RP Management LLC | Chairman | 2003 | | Cibus Ltd. | Chairman | - | | Nucelis, Inc. | Chairman | - | | Patient Choice Healthcare, Inc. | Director | - | | Syntax ETF Trust | Chief Executive Officer & Trustee | 2017 | | Cibus US LLC | Chairman | - | | ITI, Inc. /New York/ | Director | 2014 | | eReceivables LLC | Director | 2014 | | Nuredis, Inc. | Director | - | | Balfour Venture Partners | Managing Member | - |
| | Participations de Rory B. Riggs | | | | Nom | Actions | % | Valorisation | | Royalty Pharma Plc | 6 732 680 | 3,15% | 278 598 298 USD | FibroGen, Inc. (FGEN)
(Recherche biotechnologique et mdicale) | 996 763 | 1,10% | 44 684 885 USD | Intra-Cellular Therapies, Inc. (ITCI)
(Recherche biotechnologique et mdicale) | 287 652 | 0,43% | 5 241 019 USD | StageZero Life Sciences Ltd. (SZLS)
(Recherche biotechnologique et mdicale) | 14 222 629 | 3,63% | 867 580 USD | Royalty Pharma plc (RPRX)
(Produits pharmaceutiques) | 15 000 | 0,0041% | 620 700 USD |
| | Rory B. Riggs: Rseau personnel | | | | Nom | Socits lies | | Eugene Linden | Cibus US LLC
Cibus Global, Ltd.
Cibus Ltd. | | Mark Terrence Finn | Cibus US LLC
Cibus Global, Ltd.
Cibus Ltd. | | Keith Walker | Cibus Global, Ltd.
Cibus US LLC
Cibus Ltd. | | Peter Beetham | Cibus Global, Ltd.
Cibus US LLC
Cibus Ltd. | | Gerhard Prante | Cibus US LLC
Cibus Global, Ltd.
Cibus Ltd. | | Jean Pierre Lehmann | Cibus US LLC
Cibus Global, Ltd.
Cibus Ltd. | | Alain Pompidou | Cibus US LLC
Cibus Global, Ltd.
Cibus Ltd. | | Greg Gocal | Cibus US LLC
Cibus Global, Ltd.
Cibus Ltd. | | Chris D. Alafi | Intra-Cellular Therapies, Inc.
Nuredis, Inc.
ITI, Inc. /New York/ | | Richard Alan Lerner | Intra-Cellular Therapies, Inc.
ITI, Inc. /New York/
| | |